I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

Disclaimers

Data Interpretation & Reporting Level

Quantitative Techniques & Analytics

Product Definitions and Scope of the Study

qPCR

dPCR

I. EXECUTIVE SUMMARY

1.INDUSTRY OVERVIEW

Polymerase Chain Reaction (PCR): An Integral Part of Gene Amplification & Quantification

Sizing the Market

Developing Countries Exude Tremendous Potential for Growth

qPCR Remains the Mainstay Technology

Research and Testing – Major Application Markets

Striking the Right Balance between qPCR and Dpcr in Research Laboratories

qPCR- A Suitable Tool for Gene Expression and Validation

A Peek into Select qPCR Systems Available in Marketplace

Thermo Fisher Life Sciences Prism 7000 Series

Thermo Fisher Life Sciences ViiA 7

Thermo Fisher Life Sciences QuantStudio

Cepheid SmartCycler Platform

Roche LightCycler Platform

Roche FLOW

As qPCR Technology Matures, Saturation is Imminent

Table 1: Global qPCR Instrumentation Market by Category (2017): Percentage Share Breakdown of Annual Revenues for Reagents and Instruments (includes corresponding Graph/Chart)

Digital PCR to Take Quantification of Nucleic Acids to the Next Level

dPCR – A Valuable Tool in Virology Research

High Sensitivity in Viral Detection

Creation and Validation of Viral Reference Standards

High-Precision Quantification

Sales of Digital PCR to Skyrocket in the Near Term

dPCR Holds Potential to Capture Application Markets from Predecessor Technologies

New dPCR Systems to Capture a Bigger Slice of the Market

Table 2: A Comparison of Select Leading dPCR Systems

QuantStudio 3D Digital PCR System

QuantStudio 12K

BioMark HD system

QX100 droplet digital PCR System

RainDrop Systems

High Installation Cost Remains a Roadblock to Widespread Adoption of dPCR

Despite Onslaught of Digital PCR, qPCR Maintains Relevance

2.GROWTH DRIVERS, MARKET TRENDS & ISSUES

Increasing Incidence and Prevalence of Cancer: A Grim Reality Driving Demand for qPCR and dPCR

Table 3: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart)

Table 4: New Cancer Cases in the World by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 5: Global Cancer Incidence by Income Group: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 6: Cancer Incidence in High Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 7: Cancer Incidence in Upper Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 8: Cancer Incidence in Lower Middle Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Table 9: Cancer Incidence in Low Income Countries by Site: 2012 (in Thousands) (includes corresponding Graph/Chart)

Improving Healthcare Expenditure to Drive Demand for qPCR and dPCR-based Tests

Table 10: Healthcare Spending as % of GDP by Region (2016E) (includes corresponding Graph/Chart)

Progress in Molecular Diagnostics Spur Demand for the Gene Amplification Technologies

Prospects for Predictive Genetic Diagnostics and Testing Grow Brighter

Growing Prevalence of Genetic Disorders and Infectious Diseases Provide a Strong Case for Growth

Innovations in Instrumentation Expand Functionality and Drive Adoption

Adaptive PCR – A Recent Advancement

Expanding Scope of Applications in Applied Sciences Drive Demand for qPCR Instruments and Supplies

qPCR and NGS to Drive Single-Cell Genomics Market

Advancements in Probe Technology Enhance qPCR Sensitivity

qPCR Market to Witness Increasing Affinity for Automated and Robotic Equipment

Factors influencing Selection of Lab Robots

Lab on Chip/Microfluidic Real-time-PCR – A Game Changer in the Offing

Two Types of Microfluidic Designs

Advantages of Lab on Chip PCR

Roadblocks in the Path to Development

New Developments in Lab-on-chip PCR

dPCR for Liquid Biopsies

Areas of Digital PCR has Immense Potential

ddPCR – The More Advanced Digital Approach to dPCR

Droplet digital PCR Finds Increasing Application in Life Sciences Research

ddPCR Gains Traction in Cancer Diagnosis

Monitoring Disease Progression in HIV Studies

Analysis of Genetically Modified Organisms in Edible Products

RT-ddPCR Techniques Applied for Quantitating RNA Viruses in Water Samples

Adoption of High Throughput Platforms Gains Pace

MC-ICP, A New Technique for Increasing Sensitivity of dPCR Instruments

Study Establishes High Reproducibility of dPCR

Clarity? dPCR – An Advanced dPCR for Improved Workflows

Veterinary Diagnostic Applications Yet to Embrace dPCR

Researchers Continue to Campaign for Adoption and Strict Compliance with MIQE and SPIDIA Guidelines

Alternate Technologies Pose Threat to Growth of PCR Market

New Isothermal PCR Technology – A Potential Game Changer Promising Faster PCR

3.COMPETITIVE LANDSCAPE

qPCR – A Highly Concentrated Market Place

Select qPCR Products by Company

Table 11: PCR Systems Product Portfolio of Thermo Fisher Life Sciences Solutions

Cost of PCR instruments and Reagents to Come Under Pressure

Competitive Landscape of dPCR Market

Bio-Rad Makes Rapid Strides in Life Science Arena with Two Big Deals

Qiagen Strengthens its Hold with Acquisitions

Intense Competition Triggers a Spate of M&A

Multiple Factors to Sustain Consolidation Trend in PCR Industry

Accelerated Commercialization of Products

Offering Integrated and Multi-technology Solutions

Manufacturers Step-Up Online Exposure

Manufacturers Target Expansion of Distribution Reach and Global Footprint

4.END-USE MARKET ANALYSIS

Application Areas of PCR

Medical and Diagnostics

PCR Plays a Vital Role in the Diagnosis of Infectious Diseases

Detection of Antimicrobial Resistance

PCR-Based Nucleic Acid Amplification for Detection of Antimicrobial Agents

Forensic and Paternity Testing

Food Safety

Detection and Quantification of Food Pathogens

Detection of Beneficial and Non-Pathogenic Microbes

Study of Microbial Responses to Environment

Microbial Risk Assessment

qPCR Application in Food Microbiology: Study of Select Micro-Organisms by Target Gene and Food Substrate

PCR Technique in Identification of GMOs

Research & Academics

SYBR Dye and TaqMan Techniques Popular in Research Publications

5.PRODUCT OVERVIEW

Introduction to Polymerase Chain Reaction (PCR)

Reagents and Components Required for PCR

Reaction Steps

Denaturation

Annealing

Extension

Real-Time PCR or Quantitative PCR (qPCR)

qPCR Instrumentation

Evolution

Working of qPCR Instruments

Thermal Control

Fluorimetry

DNA Detection Methods

Fluorescence Measurement

Asymmetrical dsDNA dyes

Quantification

High-Throughput qPCR

Comparison of Working of Conventional PCR versus qPCR

Drawbacks in Core PCR

Advantages of qPCR

Disadvantages of qPCR

End-Use Applications of qPCR

Factors Influencing Purchase Decisions of qPCR Systems

qPCR Consumables, Accessories and Software

DIGITAL PCR

Development of dPCR

Working Principle

Droplet dPCR

Applications of dPCR

Advantages of dPCR

6.PRODUCT INNOVATIONS/INTRODUCTIONS

Bio-Rad Rolls Out New RT-PCR Kit for Simultaneous Screening of Various Viruses

Agilent Technologies Launches AriaDx Real-Time PCR System

FORMULATRIX Introduces CONSTELLATION? Digital PCR System

Roche Rolls Out cobas? Liat? PCR System in Europe

Thermo Fisher Launches QuantStudio 5 RT PCR System

RainDance Introduces RainDrop Plus? Digital PCR System

Stilla Launches Digital PCR System

Analytik Jena Unveils qTOWER? RT PCR Thermal Cycler

Bio-Rad Rolls Out ddPCR? Supermix

Takara Bio Unveils Thermal Cycler Dice? Real Time System III

Exiqon Introduces ExiLERATE LNA? qPCR Reagents and Kits

Thermo Fisher Launches PowerUp SYBR Green PCR Master Mix

Thermo Fisher Introduces QuantStudio 3 and QuantStudio 5 RT PCR Systems

Kapa Biosystems Rolls Out KAPA PROBE FORCE qPCR Kit

Agilent Technologies Launches AriaMx System

7.RECENT INDUSTRY ACTIVITY

RainDance and Bio-Rad Ink Definitive Acquisition Agreement

Curetis Buys Gyronimo Platform from Carpegen and Systec

QIAGEN Takes Over Exiqon

LGC Takes Over Douglas Scientific

Bio-Rad Secures CE Marking for QX200? Droplet Digital? PCR System

Roche to Take Over Kapa Biosystems

LGC to Acquire Biosearch

Thermo Fisher Scientific Completes Take Over of Life Technologies

8.FOCUS ON SELECT PLAYERS

Agilent Technologies, Inc. (USA)

Becton, Dickinson and Company (USA)

BioFire Diagnostics, Inc. (USA)

Bio-Rad Laboratories, Inc. (USA)

Cepheid (USA)

Eppendorf AG (Germany)

F. Hoffmann-La Roche Ltd. (Switzerland)

Fluidigm Corporation (USA)

Promega Corporation (USA)

QIAGEN N.V. (Netherlands)

RainDance Technologies, Inc. (USA)

Takara Bio, Inc. (Japan)

Thermo Fisher Scientific Inc. (USA)

9.GLOBAL MARKET PERSPECTIVE

Table 12: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 13: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 14: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Analytics by Product Category

Table 15: World Recent Past, Current & Future Analysis for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 16: World Historic Review for qPCR and dPCR Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 17: World 14-Year Perspective for qPCR and dPCR Reagents by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Table 18: World Recent Past, Current & Future Analysis for qPCR and dPCR Instruments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 19: World Historic Review for qPCR and dPCR Instruments by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 20: World 14-Year Perspective for qPCR and dPCR Instruments by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa and Latin America Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Analysis by Product Segment

Table 21: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 22: World Historic Review for qPCR and dPCR Instrumentation and Reagents by Product Segment - qPCR and dPCR Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 23: World 14-Year Perspective for qPCR and dPCR Instrumentation and Reagents by Product Segment - Percentage Breakdown of Revenues for qPCR and dPCR Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Table 24: World Recent Past, Current & Future Analysis for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 25: World Historic Review for qPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 26: World 14-Year Perspective for qPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Table 27: World Recent Past, Current & Future Analysis for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 28: World Historic Review for dPCR Instrumentation and Reagents by Product Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 29: World 14-Year Perspective for dPCR Instrumentation and Reagents by Product Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Analytics by End-Use

Table 30: World Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/ Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 31: World Historic Review for qPCR and dPCR Instrumentation and Reagents by End-Use Segment - Educational/Research, Testing Laboratories and Pharma Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 32: World 14-Year Perspective for qPCR and dPCR Instrumentation by End-Use Segment - Percentage Breakdown of Revenues for Educational/Research, Testing Laboratories and Pharma Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

III. MARKET

1.THE UNITED STATES

A. Market Analysis

Current and Future Analysis

qPCR Vs. dPCR Instrumentation is the US

Cancer Stats

Cancer Incidence Statistics

Table 33: New Cancer Cases by Gender and Affected Site in the US (2017E) (includes corresponding Graph/Chart)

Table 34: Cancer Related Deaths by Gender in the US (2017E) (includes corresponding Graph/Chart)

Table 35: New Cancer Cases by State in the US (2017E) (includes corresponding Graph/Chart)

Cancer Mortality Statistics

Table 36: Cancer Related Deaths in the US by Gender and Body Site: 2017 (includes corresponding Graph/Chart)

Table 37: Number of Deaths Related to Major Types of Cancer in US by State: 2017E (includes corresponding Graph/Chart)

Competitive Landscape

Product Introductions

Strategic Corporate Developments

Select Key Players

B. Market Analytics

Table 38: The US Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 39: The US Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 40: The US 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

2.CANADA

A. Market Analysis

Current and Future Analysis

Cancer Statistics in Canada

Table 41: New Cancer Cases in Canada (2017E): Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart)

Table 42: New Cancer Cases in Canada by Province: 2017E (includes corresponding Graph/Chart)

Table 43: New Cancer Cases in Canada by Age Group: 2017E (includes corresponding Graph/Chart)

Table 44: Cancer Related Deaths in Canada (2017E): Percentage Breakdown of Number of Deaths by Gender and Affected Site (includes corresponding Graph/Chart)

Funglyn Biotech, Inc. – A Key Player

B. Market Analytics

Table 45: Canadian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 46: Canadian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 47: Canadian 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

3.JAPAN

A. Market Analysis

Current and Future Analysis

Product Launch

Takara Bio, Inc. – A Key Player

B. Market Analytics

Table 48: Japanese Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 49: Japanese Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 50: Japanese 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4.EUROPE

A. Market Analysis

Current and Future Analysis

PCR Reagents in Europe: An Overview

qPCR Competitive Landscape

Strategic Corporate Development

B. Market Analytics

Table 51: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 52: European Historic Review for qPCR and dPCR Instrumentation by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 53: European 14-Year Perspective for qPCR and dPCR Instrumentation by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, and Rest of Europe Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

Table 54: European Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 55: European Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 56: European 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4a.FRANCE

A. Market Analysis

Current and Future Analysis

Product Launch

B. Market Analytics

Table 57: French Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 58: French Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 59: French 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4b.GERMANY

A. Market Analysis

Current and Future Analysis

Product Launch

Strategic Corporate Development

Eppendorf Ag – A Key German Player

B. Market Analytics

Table 60: German Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 61: German Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 62: German 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4c.ITALY

Market Analysis

Table 63: Italian Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 64: Italian Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 65: Italian 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4d.THE UNITED KINGDOM

Market Analysis

Table 66: The UK Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 67: The UK Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 68: The UK 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

4e.REST OF EUROPE

A. Market Analysis

Current and Future Analysis

Product Launches

Strategic Corporate Development

Key Players

B. Market Analytics

Table 69: Rest of Europe Recent Past, Current & Future Analysis for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2016 through 2024 (includes corresponding Graph/Chart)

Table 70: Rest of Europe Historic Review for qPCR and dPCR Instrumentation by Category - Reagents and Instruments Markets Independently Analyzed with Annual Revenue Figures in US$ Thousand for the Years 2011 through 2015 (includes corresponding Graph/Chart)

Table 71: Rest of Europe 14-Year Perspective for qPCR and dPCR Instrumentation by Category - Percentage Breakdown of Revenues for Reagents and Instruments Markets for the Years 2011, 2017 & 2024 (includes corresponding Graph/Chart)

5.ASIA-PACIFIC

Mark